ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+20.41%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
Cap. Flow
+$1.3M
Cap. Flow %
0.49%
Top 10 Hldgs %
98.33%
Holding
14
New
–
Increased
2
Reduced
–
Closed
1

Top Buys

1
SYRE icon
Spyre Therapeutics
SYRE
$3.7M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
$2.22M

Top Sells

1
RCUS icon
Arcus Biosciences
RCUS
$4.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$130M 49.65%
3,989,412
– –
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$53.6M 20.44%
1,123,630
– –
TECX
3
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$17.6M 6.72%
1,009,779
– –
SYRE icon
4
Spyre Therapeutics
SYRE
$996M
$15.6M 5.97%
1,691,151
+400,000
+31% +$3.7M
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.41B
$15.2M 5.8%
1,025,000
+150,000
+17% +$2.22M
BCEL
6
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$8.25M 3.15%
387,653
– –
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
$8.17M 3.12%
1,386,338
– –
MRKR icon
8
Marker Therapeutics
MRKR
$12M
$4.14M 1.58%
2,000,000
– –
VIRX
9
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.66M 1.02%
10,100,000
– –
ZSAN
10
DELISTED
Zosano Pharma Corporation
ZSAN
$2.33M 0.89%
2,718,226
– –
VRNA
11
Verona Pharma
VRNA
$9.16B
$2.07M 0.79%
443,596
– –
NBRV
12
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.29M 0.49%
1,910,287
– –
ACRS icon
13
Aclaris Therapeutics
ACRS
$209M
$1.03M 0.39%
634,455
– –
RCUS icon
14
Arcus Biosciences
RCUS
$1.13B
– –
-333,333
Closed -$4.63M